[Federal Register Volume 78, Number 160 (Monday, August 19, 2013)]
[Notices]
[Pages 50421-50422]
[FR Doc No: 2013-19962]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2000-D-0187 (formerly Docket No. 2000D-1267)]

Guidance for Industry: Recommendations for Donor Questioning,
Deferral, Reentry, and Product Management To Reduce the Risk of
Transfusion-Transmitted Malaria; Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the
availability of a document entitled ``Guidance for Industry:
Recommendations for Donor Questioning, Deferral, Reentry and Product
Management to Reduce the Risk of Transfusion-Transmitted Malaria''
dated August 2013. The guidance document provides blood establishments
that collect blood and blood components with recommendations for
questioning and deferring donors of blood and blood components,
allowing their reentry, and product management to reduce the risk of
transfusion-transmitted malaria. This guidance finalizes the draft
guidance of the same title dated June 2012, and supersedes the FDA
memorandum to all registered blood establishments entitled
``Recommendations for Deferral of Donors for Malaria Risk'' dated July
26, 1994. The recommendations contained in the guidance are not
applicable to donors of Source Plasma.

DATES: Submit either electronic or written comments on Agency guidances
at any time.

ADDRESSES:  Submit written requests for single copies of the guidance
to the Office of Communication, Outreach and Development (HFM-40),
Center for Biologics Evaluation and Research (CBER), Food and Drug
Administration, 1401 Rockville Pike, suite 200N, Rockville, MD 20852-
1448. Send one self-addressed adhesive label to assist the office in
processing your requests. The guidance may also be obtained by mail by
calling CBER at 1-800-835-4709 or<PHONE_NUMBER>. See the SUPPLEMENTARY
INFORMATION section for

electronic access to the guidance document.
    Submit electronic comments on the guidance to http://www.regulations.gov. Submit written comments to the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Melissa Reisman, Center for Biologics
Evaluation and Research (HFM-17), Food and Drug Administration, 1401
Rockville Pike, suite 200N, Rockville, MD 20852-1448,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Background

    FDA is announcing the availability of a guidance document entitled
``Guidance for Industry: Recommendations for Donor Questioning,
Deferral, Reentry and Product Management to Reduce the Risk of
Transfusion-Transmitted Malaria'' dated August 2013. The guidance
document provides blood establishments that collect blood and blood
components with recommendations for questioning and deferring donors of
blood and blood components, and allowing their reentry, to reduce the
risk of transfusion-transmitted malaria. This guidance document also
provides recommendations for product management, including
recommendations regarding product retrieval and quarantine, and
notification of consignees of blood and blood components in the event
that a blood establishment determines that blood or blood components
have been collected from a donor who should have been deferred due to
possible malaria risk. Finally, the guidance contains recommendations
on the implementation of FDA's recommendations, including how licensed
blood establishments must report to FDA the changes made to their donor
history questionnaires to reflect the new donor deferral
recommendations.
    In the Federal Register of July 6, 2012 (77 FR 40068), FDA
announced the availability of the draft guidance of the same title
dated June 2012. FDA received several comments on the draft guidance
and those comments were considered as the guidance was finalized.
Significant changes to the guidance include: revisions to the
definition of malaria-endemic area, malaria-endemic country and other
terms used to assess a donor's risk of malaria based on history of
travel or residence; and revisions to the recommendations regarding
consignee notification and reporting of biological product deviations
for acellular blood components collected from a donor at risk for
malaria. Based on the revised definition of malaria-endemic area and
current epidemiological data, donors who travel to the Mexican States
of Quintana Roo or Jalisco would be eligible for donation without any
deferral, provided the donors meet all other eligibility criteria.
However, if malaria transmission in these States changes over time, the
donor deferral recommendations would encompass donors who travel to
these areas. The guidance announced in this notice finalizes the draft
guidance dated June 2012, and supersedes the FDA memorandum to all
registered blood establishments entitled ``Recommendations for Deferral
of Donors for Malaria Risk,'' dated July 26, 1994.
    The guidance is being issued consistent with FDA's good guidance
practices regulation (21 CFR 10.115). The guidance represents FDA's
current thinking on this topic. It does not create or confer any rights
for or on any person and does not operate to bind FDA or the public. An
alternative approach may be used if such approach satisfies the
requirements of the applicable statutes and regulations.

II. Paperwork Reduction Act of 1995

    This guidance refers to previously approved collections of
information found in FDA regulations. These collections of information
are subject to review by the Office of Management and Budget (OMB)
under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520). The
collections of information in 21 CFR part 640 and 21 CFR 630.6 have
been approved under OMB control number 0910-0116. The collections of
information in 21 CFR 606.171 have been approved under OMB control
number 0910-0458.

III. Comments

    Interested persons may submit either electronic comments regarding
this document to http://www.regulations.gov or written comments to the
Division of Dockets Management (see ADDRESSES). It is only necessary to
send one set of comments. Identify comments with the docket number
found in brackets in the heading of this document. Received comments
may be seen in the Division of Dockets Management between 9 a.m. and 4
p.m., Monday through Friday, and will be posted to the docket at http://www.regulations.gov.

IV. Electronic Access

    Persons with access to the Internet may obtain the guidance at
either http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm or http://www.regulations.gov.

    Dated: August 13, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-19962 Filed 8-16-13; 8:45 am]
BILLING CODE 4160-01-P


[Federal Register Volume 88, Number 2 (Wednesday, January 4, 2023)]
[Notices]
[Page 353]
[FR Doc No: 2022-28556]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2021-0083; FRL-9409-08-OCSPP]

Pesticide Product Registration; Receipt of Applications for New
Active Ingredients November 2022

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: EPA has received applications to register pesticide products
containing active ingredients not included in any currently registered
pesticide products. Pursuant to the Federal Insecticide, Fungicide, and
Rodenticide Act (FIFRA), EPA is hereby providing notice of receipt and
opportunity to comment on these applications.

DATES: Comments must be received on or before February 3, 2023.

ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPP-2021-0083, through the Federal eRulemaking
Portal at https://www.regulations.gov. Follow the online instructions
for submitting comments. Do not submit electronically any information
you consider to be Confidential Business Information (CBI) or other
information whose disclosure is restricted by statute. Additional
instructions on commenting and visiting the docket, along with more
information about dockets generally, is available at https://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: Charles Smith, Biopesticides and
Pollution Prevention Division (BPPD) (7511M), main telephone number:
(202) 566-1400, email address: [email protected]; or Dan
Rosenblatt, Registration Division (RD) (7505T), main telephone number:
(202) 566-2875, email address: [email protected]. The mailing address
for each contact person is Office of Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-
0001. As part of the mailing address, include the contact person's
name, division, and mail code. The division to contact is listed at the
end of each application summary.

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
The following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them.
Potentially affected entities may include:
     Crop production (NAICS code 111).
     Animal production (NAICS code 112).
     Food manufacturing (NAICS code 311).

B. What should I consider as I prepare my comments for EPA?

    1. Submitting CBI. Do not submit this information to EPA through
https://www.regulations.gov or email. Clearly mark the part or all of
the information that you claim to be CBI. For CBI information in a disk
or CD-ROM that you mail to EPA, mark the outside of the disk or CD-ROM
as CBI and then identify electronically within the disk or CD-ROM the
specific information that is claimed as CBI. In addition to one
complete version of the comment that includes information claimed as
CBI, a copy of the comment that does not contain the information
claimed as CBI must be submitted for inclusion in the public docket.
Information so marked will not be disclosed except in accordance with
procedures set forth in 40 CFR part 2.
    2. Tips for preparing your comments. When preparing and submitting
your comments, see the commenting tips at https://www.epa.gov/dockets/commenting-epa-dockets.

II. Registration Applications

    EPA has received applications to register pesticide products
containing active ingredients not included in any currently registered
pesticide products. Pursuant to the provisions of FIFRA section 3(c)(4)
(7 U.S.C. 136a(c)(4)), EPA is hereby providing notice of receipt and
opportunity to comment on these applications. Notice of receipt of
these applications does not imply a decision by the Agency on these
applications. For actions being evaluated under EPA's public
participation process for registration actions, there will be an
additional opportunity for public comment on the proposed decisions.
Please see EPA's public participation website for additional
information on this process (https://www2.epa.gov/pesticide-registration/public-participation-process-registration-actions).
Notice of Receipt--New Active Ingredients
    File Symbol: 264-REEI, 264-REGR, 264-REGE, 264-REGG. Docket ID
number: EPA-HQ-OPP-2022-0871. Applicant: Bayer CropScience LP, 800 N
Lindbergh Blvd., St. Louis, MO 63167. Product name: Spidoxamat
technical, plenexos care, pridixor, plenexos smart. Active ingredient:
Insecticide and spidoxamat at 97.04%, 4.8%, 82.84%, 7.2%. Proposed
classification/Use: Citrus fruit (CG 10-10); pome fruit (CG 11-10);
small fruit vine climbing--except fuzzy kiwifruit (crop subgroup 13-
07F); stone fruit (CG 12-12); tree nuts (group 14-12, except almond).
Contact: RD.
    File Symbol: 29964-GU. Docket ID number: EPA-HQ-OPP-2022-0930.
Applicant: Pioneer HiBred International, Inc., 7100 NW 62 Avenue, P.O.
Box 1000, Johnston, IA 50131-1000. Product name: DP915635-4 Corn.
Active ingredient: Insecticide; ophioglossum pendulum IPD079Ea
insecticidal protein and the genetic material necessary (PHP83175 TDNA)
for its production in corn event DP[hyphen]915635-4. Proposed use:
Plant-incorporated protectant (PIP) for corn. Contact: BPPD.
    File Symbol: 72662-I. Docket ID number: EPA-HQ-OPP-2022-0915.
Applicant: Oro-Agri Inc. 2788 S Maple Ave., Fresno, CA. Product name:
OR-097. Active ingredient: Sweet orange oil 5.5%. Product Type:
Fungicide, insecticide, acaricide. Proposed classification/Use:
Agricultural crops, greenhouse plants, nursery, turf. Contact: BPPD.
    File Symbol: 72662-O. Docket ID number: EPA-HQ-OPP-2022-0915.
Applicant: Oro-Agri Inc. 2788 S Maple Ave., Fresno, CA. Product name:
Oro orange oil. Active ingredient: Sweet orange oil at 100%. Product
Type: Fungicide, insecticide, acaricide. Proposed classification/use:
For manufacturing or formulating of product to be used on agricultural
crops, greenhouse plants, nursery, turf. Contact: BPPD.
    File Symbol: 72662-T. Docket ID number: EPA-HQ-OPP-2022-0915.
Applicant: Oro-Agri, Inc. 2788 S Maple Ave., Fresno, CA. Product name:
OR-009. Active ingredient: Sweet orange oil 6.0%. Product type:
Fungicide, insecticide, acaricide. Proposed classification/use:
Agricultural crops, greenhouse plants, nursery, turf. Contact: BPPD.
    Authority: 7 U.S.C. 136 et seq.

    Dated: December 21, 2022.
Delores Barber,
Director, Information Technology and Resources Management Division,
Office of Program Support.
[FR Doc. 2022-28556 Filed 1-3-23; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 85, Number 76 (Monday, April 20, 2020)]
[Proposed Rules]
[Pages 21820-21821]
[FR Doc No: 2020-07922]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Pipeline and Hazardous Materials Safety Administration

49 CFR Parts 191 and 192

[Docket No. PHMSA-2019-0131]

Pipeline Safety: Farm Taps Frequently Asked Questions

AGENCY: Pipeline and Hazardous Materials Safety Administration (PHMSA);
DOT.

ACTION: Announcement of frequently asked questions; request for
comments.

-----------------------------------------------------------------------

SUMMARY: The Pipeline and Hazardous Materials Safety Administration
(PHMSA) is making available for comment a set of proposed frequently
asked questions (FAQs) regarding individual service lines directly
connected to production, gathering, or transmission pipelines, commonly
referred to as farm taps. The proposed FAQs address the applicability
of the Federal Pipeline Safety Regulations and include guidance related
to the Exercise of Enforcement Discretion Regarding Farm Taps published
in the Federal Register on March 26, 2019.

DATES: Persons interested in submitting comments on the proposed farm
tap FAQs must do so by June 19, 2020.

ADDRESSES: You may submit comments, identified by docket number PHMSA-
2019-0131, by any of the following methods:
     E-Gov Web: http://www.regulations.gov. This site allows
the public to enter comments on any Federal Register notice issued by
any agency. Follow the online instructions for submitting comments.
     Mail: Docket Management System: U.S. Department of
Transportation, 1200 New Jersey Avenue SE, West Building Ground Floor,
Room W12-140, Washington, DC 20590-0001.
     Hand Delivery: DOT Docket Management System: West Building
Ground Floor, Room W12-140, 1200 New Jersey Avenue SE, between 9:00
a.m. and 5:00 p.m. EST, Monday through Friday, except federal holidays.
     Fax:<PHONE_NUMBER>.
     Instructions: Identify the docket PHMSA-2019-0131, at the
beginning of your comments. If you submit your comments by mail, submit
two copies. If you wish to receive confirmation that PHMSA received
your comments, include a self-addressed stamped postcard. Internet
users may submit comments at http://www.regulations.gov.
     Privacy Act: DOT may solicit comments from the public
regarding certain general notices. DOT posts these comments, without
edit, including any personal information the commenter provides, to
www.regulations.gov, as described in the system of records notice (DOT/
ALL-14 FDMS), which can be reviewed at www.dot.gov/privacy.
     Confidential Business Information: Confidential Business
Information (CBI) is commercial or financial information that is both
customarily and actually treated as private by its owner. Under the
Freedom of Information Act (FOIA) (5 U.S.C. 552), CBI is exempt from
public disclosure. If your comments responsive to this document contain
commercial or financial information that is customarily treated as
private, that you actually treat as private, and that is relevant or
responsive to this document, it is important that you clearly designate
the submitted comments as CBI. Pursuant to 49 CFR 190.343, you may ask
PHMSA to give confidential treatment to information you give to the
agency by taking the following steps: (1) Mark each page of the
original document submission containing CBI as ``Confidential''; (2)
send PHMSA, along with the original document, a second copy of the
original document with the CBI deleted; and (3) explain why the
information you are submitting is CBI. Unless you are notified
otherwise, PHMSA will treat such marked submissions as confidential
under FOIA, and they will not be placed in the public docket of this
document. Submissions containing CBI should be sent to Sayler Palabrica
at DOT, PHMSA, PHP-30, 1200 New Jersey Avenue SE, PHP-30, Washington,
DC 20590-0001.
    Any commentary PHMSA receives that is not specifically designated
as CBI will be placed in the public docket for this matter.
     Docket: For access to the docket to read background
documents or comments received, go to http://www.regulations.gov.
Follow the online instructions for accessing the dockets.
Alternatively, you may review the documents in person at the street
address listed above.

FOR FURTHER INFORMATION CONTACT: General: Mr. Sayler Palabrica by
telephone at<PHONE_NUMBER>, or email at<EMAIL_ADDRESS>    Technical: Mr. Chris McLaren by telephone at<PHONE_NUMBER>, or email
at<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: PHMSA provides written clarification of the
pipeline safety regulations (49 CFR parts 190-199) in the form of FAQs
and other guidance materials. PHMSA is requesting public comment on a
set of proposed FAQs intended to clarify, explain, and promote better
understanding and implementation of the requirements in Parts 191 and
192 with respect to individual service pipelines directly connected to
transmission, gathering, or production pipelines. These facilities are
typically located in rural areas and are commonly known as ``farm
taps.''
    These proposed FAQs reflect PHMSA's current application of the
regulations to the specific implementation scenarios presented.
However, there are many situations and configurations in which farm
taps exist in gas pipeline systems, and individual FAQs cannot account
for all possible scenarios. Operators may request written regulatory
interpretations from PHMSA regarding specific situations in accordance
with Sec.  190.11.
    FAQs are provided to help the regulated community understand how to
comply with the regulations, but they are not substantive rules
themselves and do not create legally enforceable rights, assign duties,
or impose new obligations not otherwise contained in the existing
regulations and standards. However, an operator who is able to
demonstrate compliance with the FAQs is likely to be able to
demonstrate compliance with the relevant regulations. If a different
course of action is taken by a pipeline operator, the operator must be
able to demonstrate that its conduct is in accordance with the
regulations.
    On January 23, 2017, PHMSA published a final rule titled ``Operator
Qualification, Cost Recovery, Accident and Incident Notification, and
Other Pipeline Safety Changes'' in the Federal Register (82 FR 7972).
This final rule, effective March 24, 2017, excepted individual service
lines directly connected to a transmission, gathering, or production
pipeline from the distribution integrity management program (DIMP)
regulations at Sec.  192.1003(b). Instead, PHMSA added Sec.  192.740,
requiring periodic inspection and maintenance for pressure-regulating,
limiting, and overpressure protection devices on individual service
lines directly connected to production, gathering, or transmission
pipelines.

PHMSA adopted this approach after working with stakeholders to best
identify how to address risks to the integrity of farm taps in an
appropriate and cost-effective manner.
    After the publication of the rule, industry stakeholders commented
that PHMSA had underestimated the costs of compliance with the new
Sec.  192.740 farm tap inspection requirements, and that existing DIMP
requirements, in conjunction with other current requirements such as
Sec.  192.723(b)(2) leak surveys, could provide an equivalent level of
safety. As part of DOT's regulatory review process, PHMSA is
considering changes to the requirements for maintaining pressure-
regulating, limiting, and overpressure protection devices on farm taps
in the future.
    On March 26, 2019, PHMSA issued an Announcement of Enforcement
Discretion (84 FR 11253) that provides operators with the flexibility
to address the safety of pressure control, limiting, and overpressure
protection devices on farm taps under either Sec.  192.740 or their
DIMP, as specified by Sec.  192.1003 prior to its revision.
    To help operators better understand the applicability of Sec.
192.740 and other issues related to farm taps, PHMSA is issuing these
proposed FAQs. PHMSA invites interested parties to review the proposed
FAQs and submit written comments, data, or other information. Other
topics addressed in the proposed FAQs include how to determine if a
farm tap is regulated; reporting requirements for distribution services
from an unregulated source pipeline; the applicability of operation and
maintenance requirements; regulatory definitions; the applicability of
certain requirements to existing facilities; testing requirements; and
other Part 192 requirements. When finalized, these FAQs will supersede
FAQ C.3.7 in the Distribution Integrity Management Frequently Asked
Questions document at: https://www.phmsa.dot.gov/pipeline/gas-distribution-integrity-management/gas-distribution-integrity-management-faqs.
    The proposed FAQs and other supporting documents are available
online on the Federal eRulemaking Portal, https://www.regulations.gov;
search for Docket No. PHMSA-2019-0131. Before finalizing the proposed
FAQs, PHMSA will evaluate all comments received on or before the
comment closing date. Comments received after the closing date will be
evaluated to the extent practicable. Once finalized, PHMSA's FAQs will
be posted on PHMSA's public website at https://www.phmsa.dot.gov.

    Issued in Washington, DC, on April 9, 2020, under authority
delegated in 49 CFR 1.97.
Alan K. Mayberry,
Associate Administrator for Pipeline Safety.
[FR Doc. 2020-07922 Filed 4-17-20; 8:45 am]
 BILLING CODE 4910-60-P


[Federal Register Volume 79, Number 186 (Thursday, September 25, 2014)]
[Notices]
[Pages 57544-57545]
[FR Doc No: 2014-22800]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CP14-549-000]

Dominion Transmission, Inc., Tennessee Gas Pipeline Company,
L.L.C.; Notice of Application

    Take notice that on September 5, 2014, Dominion Transmission, Inc.
(Dominion), 120 Tredegar Street, Richmond, VA 23219 and Tennessee Gas
Pipeline Company, L.L.C. (Tennessee), 1001 Louisiana Street, Suite
1000, Houston, TX 77002, jointly filed an application in Docket No.
CP14-549-000 pursuant to section 7(c) of the Natural Gas Act (NGA), and
Part 157 of the Commission's regulations, for a certificate of public
convenience and/or necessity requesting authorization to revise the
active boundary and establish a protective boundary for the Harrison
Storage Pool located in Potter and Tioga Counties, Pennsylvania and
Steuben County, New York. The proposed expansion would increase the
storage reservoir by 1,317.02 acres and establish a 2,000-foot buffer
area around the reservoir containing 5,895.36 acres, all as more fully
set forth in the application which is on file with the Commission and
open for public inspection. The filing may also be viewed on the web at
http://www.ferc.gov using the ``eLibrary'' link. Enter the docket
number excluding the last three digits in the docket number field to
access the document. For assistance, contact FERC at
<EMAIL_ADDRESS>or call toll-free,<PHONE_NUMBER> or TTY,
(202) 502-8659.
    Any questions regarding this application may be directed to Richard
Jessee, Regulatory and Certificate Analyst, Dominion Transmission,
Inc., 701 East Cary Street, Richmond, Virginia 23219, or by calling
804-771-3704, facsimile no.<PHONE_NUMBER>, or email at
<EMAIL_ADDRESS>    Pursuant to section 157.9 of the Commission's rules, 18 CFR 157.9,

within 90 days of this Notice the Commission staff will either:
Complete its environmental assessment (EA) and place it into the
Commission's public record (eLibrary) for this proceeding; or issue a
Notice of Schedule for Environmental Review. If a Notice of Schedule
for Environmental Review is issued, it will indicate, among other
milestones, the anticipated date for the Commission staff's issuance of
the final environmental impact statement (FEIS) or EA for this
proposal. The filing of the EA in the Commission's public record for
this proceeding or the issuance of a Notice of Schedule for
Environmental Review will serve to notify federal and state agencies of
the timing for the completion of all necessary reviews, and the
subsequent need to complete all federal authorizations within 90 days
of the date of issuance of the Commission staff's FEIS or EA.
    There are two ways to become involved in the Commission's review of
this project. First, any person wishing to obtain legal status by
becoming a party to the proceedings for this project should, on or
before the comment date stated below, file with the Federal Energy
Regulatory Commission, 888 First Street NE., Washington, DC 20426, a
motion to intervene in accordance with the requirements of the
Commission's Rules of Practice and Procedure (18 CFR 385.214 or
385.211) and the Regulations under the NGA (18 CFR 157.10). A person
obtaining party status will be placed on the service list maintained by
the Secretary of the Commission and will receive copies of all
documents filed by the applicant and by all other parties. A party must
submit 7 copies of filings made with the Commission and must mail a
copy to the applicant and to every other party in the proceeding. Only
parties to the proceeding can ask for court review of Commission orders
in the proceeding.
    However, a person does not have to intervene in order to have
comments considered. The second way to participate is by filing with
the Secretary of the Commission, as soon as possible, an original and
two copies of comments in support of or in opposition to this project.
The Commission will consider these comments in determining the
appropriate action to be taken, but the filing of a comment alone will
not serve to make the filer a party to the proceeding. The Commission's
rules require that persons filing comments in opposition to the project
provide copies of their protests only to the party or parties directly
involved in the protest.
    Persons who wish to comment only on the environmental review of
this project should submit an original and two copies of their comments
to the Secretary of the Commission. Environmental commenter's will be
placed on the Commission's environmental mailing list, will receive
copies of the environmental documents, and will be notified of meetings
associated with the Commission's environmental review process.
Environmental commenter's will not be required to serve copies of filed
documents on all other parties. However, the non-party commentary, will
not receive copies of all documents filed by other parties or issued by
the Commission (except for the mailing of environmental documents
issued by the Commission) and will not have the right to seek court
review of the Commission's final order.
    The Commission strongly encourages electronic filings of comments,
protests and interventions in lieu of paper using the ``eFiling'' link
at http://www.ferc.gov. Persons unable to file electronically should
submit an original and 5 copies of the protest or intervention to the
Federal Energy Regulatory Commission, 888 First Street NE., Washington,
DC 20426. See, 18 CFR 385.2001(a)(1)(iii) and the instructions on the
Commission's Web site under the ``e-Filing'' link.
    Comment Date: October 6, 2014.

    Dated: September 15, 2014.
 Kimberly D. Bose,
Secretary.
[FR Doc. 2014-22800 Filed 9-24-14; 8:45 am]
BILLING CODE 6717-01-P